•Eligible, commercially insured patients may be able to receive medication at no cost for up to three months while they await reauthorization or appeals outcome
•Available in a 30day supply. Refills are subject to limitations
•For NGENLA patients with a new to market block on the medication, NGENLA may be provided for up to 180 days
•HCP and patient should complete the Pfizer Bridge Program Enrollment Form and fax to 8004792562
•For assistance or additional information, call 18006451280, Monday – Friday, 9 am–7 pm ET